Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00180271 · ClinicalTrials.gov registry record · NA
MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy
A NA study of Congestive Heart Failure and Tachycardia, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 1,820
- Enrollment target
- 1
- Study location
NCT00180271 is a NA study of Congestive Heart Failure and Tachycardia that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,820 participants, above the 294-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (519% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00180271, a NA study of Congestive Heart Failure and Tachycardia, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,820 participants
- Enrollment target
- 1
- Study location
Study Summary
The MADIT-CRT trial is designed to determine if combined implantable cardiac defibrillator (ICD)-cardiac resynchronization therapy (CRT-D) will reduce the risk of mortality and heart failure (HF) events by approximately 25%, in subjects who are in New York Heart Association (NYHA) functional Class II with non-ischemic or ischemic cardiomyopathy and subjects who are in NYHA functional Class I with ischemic cardiomyopathy, left ventricular dysfunction (ejection fraction \[EF\] \< or = 0.30), and prolonged intraventricular conduction (QRS duration \> or = 130 ms).
Conditions Studied
Interventions
- DEVICE Implantable Cardioverter Defibrillator (ICD)
- DEVICE Cardiac resynchronization therapy with defibrillation
Study Locations (1)
New York
- Multiple locations in the US and international - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,820 participants |
| Start Date | 2004-12 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00180271
The ClinicalTrials.gov registry entry for NCT00180271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,820 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 294-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (519% higher). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Congestive Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Implantable Cardioverter Defibrillator (ICD) is the first listed.
NCT00180271 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00180271 about?
NCT00180271 is a clinical study titled "MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy". The MADIT-CRT trial is designed to determine if combined implantable cardiac defibrillator (ICD)-cardiac resynchronization therapy (CRT-D) will reduce the risk of mortality and heart failure (HF) events by approximately 25%, in subjects who are in New York Heart Association (NYHA) functional Class I...
What is the current status of trial NCT00180271?
This trial is currently completed. It is a NA study. The enrollment target is 1,820 participants. The study started on 2004-12. Estimated completion is 2010-09.
What conditions does trial NCT00180271 study?
This clinical trial studies the following conditions: Congestive Heart Failure, Tachycardia.
What interventions are being tested in trial NCT00180271?
The interventions under investigation include: Implantable Cardioverter Defibrillator (ICD) (DEVICE), Cardiac resynchronization therapy with defibrillation (DEVICE).
Who is sponsoring clinical trial NCT00180271?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00180271 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.